- Investing Ideas
- /
- French Pharmaceuticals & Biotech Undervalued based on future growth
French Pharmaceuticals & Biotech Undervalued based on future growth
Results
2
0 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
2 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
BOI | €26.70 | 0.8% | -33.6% | €463.6m | €33.30 | PE19.6x | E26.2% | 5.1% | ||
GNFT | €3.53 | 2.0% | -0.3% | €176.0m | €9.45 | PE7.9x | E41.2% | n/a |
Page 1 of 1